Follistatin inhibits the function of the oocyte-derived factor BMP-15

被引:107
作者
Otsuka, F
Moore, RK
Iemura, S
Ueno, N
Shimasaki, S
机构
[1] Univ Calif San Diego, Sch Med, Dept Reprod Med, La Jolla, CA 92093 USA
[2] Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Aichi 444, Japan
关键词
D O I
10.1006/bbrc.2001.6103
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have highlighted the importance of a novel oocyte-derived growth factor, bone morphogenetic protein-15 (BMP-15) in the regulation of proliferation and differentiation of granulosa cells in the ovary. Namely, BMP-15 stimulates granulosa cell mitosis and inhibits follicle-stimulating hormone (FSH) receptor mRNA expression in granulosa cell, thereby playing a critical role in the elaborate mechanism controlling ovarian folliculogenesis. At present, however, nothing is known about molecules which may regulate the biological activity of BMP-15. Here we demonstrate evidence that follistatin can form an inactive complex with BMP-15, through which follistatin inhibits BMP-15 bioactivities. The binding of follistatin to BMP-15 was directly demonstrated by a surface plasmon resonance biosensor, and the ability of follistatin to inhibit BMP-15 functions was determined by established BMP-15 bioassays using primary rat granulosa cells. Specifically, follistatin attenuated BMP-15 stimulation of granulosa cell proliferation and reversed BMP-15 inhibition of FSH receptor mRNA expression leading to the suppression of FSH-induced progesterone synthesis. This is the first demonstration of the biochemical interaction and biological antagonism of follistatin and BMP-15, which may be involved in the complex yet well-controlled mechanism of the regulation of follicle growth and development. (C) 2001 Elsevier Science.
引用
收藏
页码:961 / 966
页数:6
相关论文
共 34 条
[1]   Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis [J].
Aaltonen, J ;
Laitinen, MP ;
Vuojolainen, K ;
Jaatinen, R ;
Horelli-Kuitunen, N ;
Seppä, L ;
Louhio, H ;
Tuuri, T ;
Sjöberg, J ;
Bützow, R ;
Hovatta, O ;
Dale, L ;
Ritvos, O .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2744-2750
[2]   FOLLISTATIN ANTAGONIZES THE EFFECTS OF ACTIVIN-A ON STEROIDOGENESIS IN HUMAN LUTEINIZING GRANULOSA-CELLS [J].
CATALDO, NA ;
RABINOVICI, J ;
FUJIMOTO, VY ;
JAFFE, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :272-277
[3]  
DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500
[4]  
Dong LW, 1996, J MOL RECOGNIT, V9, P383, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<383::AID-JMR269>3.0.CO
[5]  
2-Z
[6]   The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes [J].
Dube, JL ;
Wang, P ;
Elvin, J ;
Lyons, KM ;
Celeste, AJ ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (12) :1809-1817
[7]   REGULATION OF INHIBIN ACTIVIN SUNBUNIT MESSENGER RIBONUCLEIC-ACIDS (MESSENGER-RNAS) BY ACTIVIN-A AND EXPRESSION OF ACTIVIN RECEPTOR MESSENGER-RNAS IN CULTURED HUMAN GRANULOSA-LUTEAL CELLS [J].
ERAMAA, M ;
HILDEN, K ;
TUURI, T ;
RITVOS, O .
ENDOCRINOLOGY, 1995, 136 (10) :4382-4389
[8]   Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner [J].
Galloway, SM ;
McNatty, KP ;
Cambridge, LM ;
Laitinen, MPE ;
Juengel, JL ;
Jokiranta, TS ;
McLaren, RJ ;
Luiro, K ;
Dodds, KG ;
Montgomery, GW ;
Beattie, AE ;
Davis, GH ;
Ritvos, O .
NATURE GENETICS, 2000, 25 (03) :279-283
[9]   Overexpression of mouse follistatin causes reproductive defects in transgenic mice [J].
Guo, QX ;
Kumar, TR ;
Woodruff, T ;
Hadsell, LA ;
DeMayo, FJ ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (01) :96-106
[10]   Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo [J].
Iemura, S ;
Yamamoto, TS ;
Takagi, C ;
Uchiyama, H ;
Natsume, T ;
Shimasaki, S ;
Sugino, H ;
Ueno, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9337-9342